These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 39135082)

  • 21. Will healthcare workers improve infection prevention and control behaviors as COVID-19 risk emerges and increases, in China?
    Lai X; Wang X; Yang Q; Xu X; Tang Y; Liu C; Tan L; Lai R; Wang H; Zhang X; Zhou Q; Chen H
    Antimicrob Resist Infect Control; 2020 Jun; 9(1):83. PubMed ID: 32527300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infection prevention and control standards and associated factors: Case study of the level of knowledge and practices among nurses in a Saudi Arabian hospital.
    Alojaimy RS; Nakamura K; Al-Sobaihi S; Tashiro Y; Watanabe N; Seino K
    J Prev Med Hyg; 2021 Jun; 62(2):E501-E507. PubMed ID: 34604592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infection prevention and control measures in audiology practice within public healthcare facilities in KwaZulu-Natal province, South Africa.
    Khan NB; Charles CR; Naidoo N; Nokubonga A; Mkhwanazi NA; Moustache HMTE
    S Afr J Commun Disord; 2019 Dec; 66(1):e1-e14. PubMed ID: 31793311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring variations in IPC competencies: a cross-sectional study among healthcare professionals in Northwest China.
    Zhao Q; Cui X; Liu T; Li H; Shi M; Wang L
    BMC Infect Dis; 2024 Apr; 24(1):420. PubMed ID: 38644476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Working practices and success of infection prevention and control teams: a scoping study.
    Hale R; Powell T; Drey NS; Gould DJ
    J Hosp Infect; 2015 Feb; 89(2):77-81. PubMed ID: 25549828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infection prevention and control in medical imaging surveys: The need to map to guidelines to address systemic issues?
    Jimenez YA; Hill S; Lewis SJ
    Infect Dis Health; 2023 May; 28(2):102-114. PubMed ID: 36707351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Barriers and facilitators to infection prevention and control in Dutch psychiatric institutions: a theory-informed qualitative study.
    Houben F; van Hensbergen M; den Heijer CDJ; Dukers-Muijrers NHTM; Hoebe CJPA
    BMC Infect Dis; 2022 Mar; 22(1):243. PubMed ID: 35277134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infection control bundles in intensive care: an international cross-sectional survey in low- and middle-income countries.
    Alp E; Cookson B; Erdem H; Rello J;
    J Hosp Infect; 2019 Mar; 101(3):248-256. PubMed ID: 30036635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advancing outbreak simulation training: a collaborative pilot study for dual-specialty medical trainees and infection prevention and control professionals.
    King A; Cairns S; Shepherd L; Barrett J; Inkster T
    J Hosp Infect; 2024 May; 147():68-76. PubMed ID: 38432585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "Infection prevention and control idea challenge" contest: a fresh view on medical education and problem solving.
    Arianpoor A; Zarifian A; Askari E; Akhavan-Rezayat A; Dayyani M; Rahimian A; Amini E; Amel R; Ziaeemehr A; Zingg W; Aelami MH; Pittet D
    Antimicrob Resist Infect Control; 2020 Feb; 9(1):26. PubMed ID: 32033592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating national infection prevention and control minimum requirements: evidence from global cross-sectional surveys, 2017-22.
    Tartari E; Tomczyk S; Twyman A; Rehse APC; Gomaa M; Talaat M; Shah AS; Sobel H; Toledo JP; Allegranzi B
    Lancet Glob Health; 2024 Oct; 12(10):e1620-e1628. PubMed ID: 39304235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigating socio-ecological factors influencing implementation of tuberculosis infection prevention and control in rural Papua New Guinea.
    Marme G; Kuzma J; Zimmerman PA; Harris N; Rutherford S
    J Public Health (Oxf); 2024 May; 46(2):267-276. PubMed ID: 38326281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A nationwide survey on the implementation of infection prevention and control components in 1442 hospitals in the Republic of Korea: comparison to the WHO Infection Prevention and Control Assessment Framework (IPCAF).
    Jeong Y; Joo H; Bahk H; Koo H; Lee H; Kim K
    Antimicrob Resist Infect Control; 2022 May; 11(1):71. PubMed ID: 35562838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Motivating healthcare professionals (nurses, nurse assistants, physicians) to integrate new practices for preventing healthcare-associated infections into the care continuum: turning Positive Deviance into positive norms.
    Gesser-Edelsburg A; Cohen R; Halavi AM; Zemach M
    BMC Infect Dis; 2021 May; 21(1):495. PubMed ID: 34049512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What is needed to sustain improvements in hospital practices post-COVID-19? a qualitative study of interprofessional dissonance in hospital infection prevention and control.
    Gilbert GL; Kerridge I
    BMC Health Serv Res; 2022 Apr; 22(1):504. PubMed ID: 35421985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risks and challenges in COVID-19 infection prevention and control in a hospital setting: Perspectives of healthcare workers in Thailand.
    Jongdeepaisal M; Chunekamrai P; Maude RR; Maude RJ
    PLoS One; 2023; 18(12):e0267996. PubMed ID: 38113209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infection prevention and control in Dutch general practices before and during the COVID-19 pandemic and its implications for pandemic preparedness and seasonal respiratory epidemics: a qualitative study on lessons learned.
    Houben F; den Heijer CDJ; Dukers-Muijrers NHTM; de Bont EGPM; Volbeda HT; Hoebe CJPA
    BMC Prim Care; 2024 Jun; 25(1):222. PubMed ID: 38902628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rationale and guidance for strengthening infection prevention and control measures and antimicrobial stewardship programs in Bangladesh: a study protocol.
    Harun MGD; Anwar MMU; Sumon SA; Hassan MZ; Mohona TM; Rahman A; Abdullah SAHM; Islam MS; Kaydos-Daniels SC; Styczynski AR
    BMC Health Serv Res; 2022 Oct; 22(1):1239. PubMed ID: 36207710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Technology for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva IPC-Think Tank (Part 2).
    Zingg W; Park BJ; Storr J; Ahmad R; Tarrant C; Castro-Sanchez E; Perencevich E; Widmer A; Krause KH; Kilpatrick C; Tomczyk S; Allegranzi B; Cardo D; Pittet D;
    Antimicrob Resist Infect Control; 2019; 8():83. PubMed ID: 31139366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.